Keywords: alkermes, fiscal-2008, income, soars, reliant, drugmaker, gaap
Alkermes' fiscal-2008 income soars on Reliant
Article | 09 June 2008
US drugmaker Alkermes' GAAP net income for the 12 months ended March 31, 2008, was $167.0 million, or $1.66 per basic and $1.62 per diluted share, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
